EU Pharma Has Three Years To Comply With New Safety Feature Rules
This article was originally published in SRA
Executive Summary
The new EU rules on the safety feature to be attached to almost all prescription medicines have finally been published, and once they kick in products will have to carry a 'unique identifier' in the form of a 2D bar code on the pack that will allow its authenticity to be verified1.
You may also be interested in...
Pink Sheet Roundtable: Experts Advise On How To Prepare For DSCSA In 2020
2020 is when supply chain partners must agree on a vision for the track-and-trace anticounterfeiting system due in November 2023, experts tell the Pink Sheet.
EU Guide Aims To Help Manufacturers Avoid Setting Off 'False Alarms' Under FMD
To reduce false alarms of counterfeits, EU tells drugmakers no lowercase, hyphens, question marks or certain letters in serial and batch numbers.
EU 'Aide-Memoire' Outlines Systems That Should Be In Place For Compliance With FMD
An EU guide sheds some light on what inspectors will be looking for in audits to ensure that manufacturers have the safety features required to comply with the EU's Falsified Medicines Directive.